Novel Anticancer Agents
Strategies for Discovery and Clinical Testing
- 1st Edition - December 13, 2005
- Imprint: Academic Press
- Editors: Alex A. Adjei, John K. Buolamwini
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 0 8 8 5 6 1 - 9
- eBook ISBN:9 7 8 - 0 - 0 8 - 0 5 3 7 7 5 - 7
Novel Anticancer Agents offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, tran… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteNovel Anticancer Agents offers pertinent basic science information on strategies used for the rational design and discovery of novel anticancer agents, and, in addition, translational studies involving clinical trial design and execution with these novel, mostly cytostatic agents. This book covers basic science strategies that are being used in drug discovery and preclinical evaluation focused on novel molecular targets, as well as clinical trial methodology including clinical pharmacokinetics and imaging to address issues of efficacy evaluation of the new, relatively non-cytotoxic anticancer agents.
At present, there is no book that provides such an integration of basic and clinical studies of novel anticancer agents, covering both drug discovery and translational research extensively.
- Addresses the critical issues involved in the development of novel agents for cancer therapy by experts in the field
- Presents drug discovery strategies
- Discusses regulatory issues surrounding drug development
Researchers in pharmacology and oncology (both government and industry), clinical oncologists who are in clinical research in universities or in industry, anticancer drug discovery and development scientists, research libraries, postgraduate students, fellows and general oncology practicing physicians.
- Edition: 1
- Published: December 13, 2005
- No. of pages (Hardback): 464
- No. of pages (eBook): 464
- Imprint: Academic Press
- Language: English
- Hardback ISBN: 9780120885619
- eBook ISBN: 9780080537757
AA
Alex A. Adjei
Affiliations and expertise
Mayo Clinic, Rochester, Minnesota, U.S.A.JB
John K. Buolamwini
Affiliations and expertise
University of Tennessee Health Science Center, Memphis, Tennessee, U.S.A.Read Novel Anticancer Agents on ScienceDirect